GILD shares will open in the $90 area, it would appear (on Thursday evening). The hints on Remdesivir results for COVID-19 treatment suggest a significant response among severe patients.Given that the world hangs in the balance, the stakes couldn't be higher. This stock will be the tail wagging the S&P for the next week.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.